Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SLC26A1 |
| Upstream (Parents) |
|---|
| (<<) ELF4 → SLC26A1 |
| (<<) EPHB2 → SLC26A1 |
| (<<) HBEGF → SLC26A1 |
| (<<) MAT2A → SLC26A1 |
| (<<) MPHOSPH6 → SLC26A1 |
| (<<) NBL1 → SLC26A1 |
| (<<) RAC1 → SLC26A1 |
| (<<) TMSB10 → SLC26A1 |
| (<<) TUBA1C → SLC26A1 |
| (<<) VPS37B → SLC26A1 |
| (<<) YWHAQ → SLC26A1 |
| Downstream (Children) |
|---|
| SLC26A1 → ARL4C (>>) |
| SLC26A1 → CHAC1 (>>) |
| SLC26A1 → NEUROG1 (>>) |
| SLC26A1 → PRKCQ (>>) |
| SLC26A1 → PROCR (>>) |
| SLC26A1 → RPS12 (>>) |
| SLC26A1 → WNT3 (>>) |
